Top

Notification of interruption to supply

20 March 2017

RANZCOG has been notified by Pfizer that due to manufacturing issues, the current stock of PROSTIN® E2 VAGINAL GEL 2mg is expected to be depleted by the end of March 2017, and availability of new stock is not expected until May 2017. There is no safety concern with this medicine.
 
Vaginal dinoprostone is available from another manufacturer.
 
Full Product Information for PROSTIN® E2 VAGINAL GEL can be accessed at www.pfizer.com.au
 
For any medical enquiries regarding PROSTIN® E2 VAGINAL, contact Pfizer Medical Information on 1800 675 229.
 
As RANZCOG recognises the potential impact this may have on your practice, to hospital departments across Australia, and to the women in your care, we are endeavouring to ensure all members are made aware of this important issue through multiple communication channels.


 



MEDIA CENTRE

News

Clarification

In response to the recent communique Misuse of Subspecialist Titles, the College has received valuable feedback from our members.

27/01/2020

News

Australia Day 2020 Honours

RANZCOG congratulates our Fellows who have been recognised in the 2020 Australia Day Honours List.

26/01/2020

News

Congratulations Professor John Newnham AM

RANZCOG congratulates FRANZCOG Professor John Newnham AM who has been named 2020 Senior Australian of the Year.

26/01/2020